MentionTraceStock ideas from sharp blogs, podcasts & letters

NeurAxis, Inc.

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.

SectorHealth CareTickerNRXSHeadquarters🇺🇸 United StatesWebsiteneuraxis.com

Mentions

14 mentions · latest on 15 Oct 2026

See which tracked investors hold NeurAxis, Inc. →Ownership and position changes on OwnershipTrace

Microcap OpportunitiesBlogNeurAxis: Aetna Coverage Takes PENFS Past 147 Million Lives-15 Oct 2026
Microcap OpportunitiesBlogMultibaggers Only - No Steady Eddies and No Turnarounds-6 Oct 2026
Microcap OpportunitiesBlogWe Are Now Fully Focused on Multibaggers-5 Oct 2026
Microcap OpportunitiesBlogMultibaggers, Turnarounds and Steady Eddies — September 2026-30 Sept 2026
Microcap OpportunitiesBlogBanging the Table on NeurAxis-24 Sept 2026
Microcap OpportunitiesBlogNeurAxis News: 18 Million More Insured - It’s a Bigger Deal Than You Think-16 Sept 2026
Microcap OpportunitiesBlogDoes Linzess Compete With NeurAxis IB-Stim?-13 Sept 2026
Microcap OpportunitiesBlogNeurAxis: Ten Patients, or Seven Hundred-12 Sept 2026
Microcap OpportunitiesBlogHere Come The MCO Multibaggers-6 Sept 2026
Microcap OpportunitiesBlogMultibaggers, Turnarounds and Steady Eddies-1 Sept 2026
Microcap OpportunitiesBlogMicrocap Opportunities Subscription Rate Increase-6 Aug 2026
Microcap OpportunitiesBlogNeurAxis Clearing the Deck Before News-4 Aug 2026
Microcap OpportunitiesBlogMultibaggers, Turnarounds and Steady Eddies Technical Review-3 Aug 2026
Microcap OpportunitiesBlogMultibaggers, Turnarounds and Steady Eddies-1 Aug 2026